An N-terminal pro-atrial natriuretic peptide (NT-proANP) 'aggregation-prone' segment involved in isolated atrial amyloidosis

FEBS Letters

Volumn 588, Issue 1, 2014, Pages 52-57

  Louros, Nikolaos N ^a   Iconomidou, Vassiliki A ^a   Tsiolaki, Paraskevi L ^a   Chrysina, Evangelia D ^b   Baltatzis, Georgios E ^c   Patsouris, Efstratios S ^c   Hamodrakas, Stavros J ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b INSTITUTE OF BIOLOGY   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Amyloid fibril; Cardiac amyloidose; Isolated atrial amyloidosis (IAA); N terminal pro atrial natriuretic peptide (NT proANP); Natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; CONGO RED; HEPTAPEPTIDE; AMINO TERMINAL PROATRIAL NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; LYSYLLEUCYLARGINYLALANYLLEUCYLLEUCYLTHREONINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; HEART AMYLOIDOSIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; ISOLATED ATRIAL AMYLOIDOSIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ASSEMBLY; PROTEIN LOCALIZATION; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION; X RAY DIFFRACTION; AMINO ACID SEQUENCE; BETA SHEET; HYDROGEN BOND; PROTEIN CONFORMATION; PROTEIN SYNTHESIS;

EID: 84891040226     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2013.10.049     Document Type: Article

References (49)

1. C.M. Dobson Protein folding and misfolding Nature 426 2003 884 890
2. F. Chiti, and C.M. Dobson Amyloid formation by globular proteins under native conditions Nat. Chem. Biol. 5 2009 15 22
3. M.B. Pepys The Oxford Textbook of Medicine 1996 Oxford University Press Oxford
4. J.N. Buxbaum, and R.P. Linke A molecular history of the amyloidoses J. Mol. Biol. 421 2012 142 159
5. R.E. McCarthy 3rd, and E.K. Kasper A review of the amyloidoses that infiltrate the heart Clin. Cardiol. 21 1998 547 552
6. K. Sletten, P. Westermark, and J.B. Natvig Senile cardiac amyloid is related to prealbumin Scand. J. Immunol. 12 1980 503 506
7. I. Steiner The prevalence of isolated atrial amyloid J. Pathol. 153 1987 395 398
8. S. Kawamura, M. Takahashi, T. Ishihara, and F. Uchino Incidence and distribution of isolated atrial amyloid: histologic and immunohistochemical studies of 100 aging hearts Pathol. Int. 45 1995 335 342
9. A. Goette, and C. Rocken Atrial amyloidosis and atrial fibrillation: a gender-dependent "arrhythmogenic substrate"? Eur. Heart J. 25 2004 1185 1186
10. B. Johansson, and P. Westermark The relation of atrial natriuretic factor to isolated atrial amyloid Exp. Mol. Pathol. 52 1990 266 278
11. M.P. van den Berg, G. Tjeerdsma, P. Jan de Kam, F. Boomsma, H.J. Crijns, and D.J. van Veldhuisen Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure Eur. J. Heart Fail. 4 2002 255 262
12. N. Maredia, and S.G. Ray Cardiac amyloidosis Clin. Med. 5 2005 504 509
13. G. Takemura et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis J. Am. Coll. Cardiol. 31 1998 754 765
14. R.P. Linke, C. Voigt, F.S. Storkel, and M. Eulitz N-terminal amino acid sequence analysis indicates that isolated atrial amyloid is derived from atrial natriuretic peptide Virchows Arch. B 55 1988 125 127
15. A. Pucci, J. Wharton, E. Arbustini, M. Grasso, M. Diegoli, P. Needleman, M. Vigano, and J.M. Polak Atrial amyloid deposits in the failing human heart display both atrial and brain natriuretic peptide-like immunoreactivity J. Pathol. 165 1991 235 241
16. B.S. Edwards, R.S. Zimmerman, T.R. Schwab, D.M. Heublein, and J.C. Burnett Jr. Atrial stretch, not pressure, is the principal determinant controlling the acute release of atrial natriuretic factor Circ. Res. 62 1988 191 195
17. W. Yan, F. Wu, J. Morser, and Q. Wu Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme Proc. Natl. Acad. Sci. USA 97 2000 8525 8529
18. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328
19. S.A. Waldman, R.M. Rapoport, and F. Murad Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues J. Biol. Chem. 259 1984 14332 14334
20. M.P. van den Berg, I.C. van Gelder, and D.J. van Veldhuisen Depletion of atrial natriuretic peptide during longstanding atrial fibrillation Europace 6 2004 433 437
21. T.G. Yandle, A.M. Richards, M.G. Nicholls, R. Cuneo, E.A. Espiner, and J.H. Livesey Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man Life Sci. 38 1986 1827 1833
22. A. Lerman, R.J. Gibbons, R.J. Rodeheffer, K.R. Bailey, L.J. McKinley, D.M. Heublein, and J.C. Burnett Jr. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction Lancet 341 1993 1105 1109
23. M. Lopez de la Paz, and L. Serrano Sequence determinants of amyloid fibril formation Proc. Natl. Acad. Sci. USA 101 2004 87 92
24. P.K. Teng, and D. Eisenberg Short protein segments can drive a non-fibrillizing protein into the amyloid state Protein Eng. Des. Sel. 22 2009 531 536
25. K.K. Frousios, V.A. Iconomidou, C.M. Karletidi, and S.J. Hamodrakas Amyloidogenic determinants are usually not buried BMC Struct. Biol. 9 2009 44
26. V.A. Iconomidou, D. Pheida, E.S. Hamodraka, C. Antony, A. Hoenger, and S.J. Hamodrakas An amyloidogenic determinant in n-terminal pro-brain natriuretic peptide (nt-probnp): implications for cardiac amyloidoses Biopolymers 98 2012 67 75
27. E. Gasteiger, C. Hoogland, A. Gattiker, S. Duvaud, M.R. Wilkins, R.D. Appel, and A. Bairoch Protein identification and analysis tools on the ExPASy server M.J. Walker, The Proteomics Protocols Handbook 2005 Humana Press New York 571 607
28. Oxford. Diffraction Chrysalis Promotions 2009 Oxford Diffraction Ltd. Abingdon, Oxfordshire, England
29. A.G.W. Leslie, and H.R. Powell Processing diffraction data with mosflm R. Read, J.L. Sussman, Evolving Methods for Macromolecular Crystallography 2007 Springer Dordrecht, The Netherlands 978-1-4020-6314-5 41 51
30. G. Romhanyi Selective differentiation between amyloid and connective tissue structures based on the collagen specific topo-optical staining reaction with Congo red Virchows Arch. A 354 1971 209 222
31. A. Savitsky, and M.J.E. Golay Smoothing and differentiation of data by simplified least-squares procedures Anal. Chem. 36 1964 1627 1639
32. L. Kreplak, and U. Aebi From the polymorphism of amyloid fibrils to their assembly mechanism and cytotoxicity Adv. Protein Chem. 73 2006 217 233
33. S.J. Hamodrakas, A. Hoenger, and V.A. Iconomidou Amyloid fibrillogenesis of silkmoth chorion protein peptide-analogues via a liquid-crystalline intermediate phase J. Struct. Biol. 145 2004 226 235
34. J. Moreth, K.S. Kroker, D. Schwanzar, C. Schnack, C.A. von Arnim, B. Hengerer, H. Rosenbrock, and L. Kussmaul Globular and protofibrillar abeta aggregates impair neurotransmission by different mechanisms Biochemistry 52 2013 1466 1476
35. V.A. Iconomidou, A. Leontis, A. Hoenger, and S.J. Hamodrakas Identification of a novel 'aggregation-prone'/'amyloidogenic determinant' peptide in the sequence of the highly amyloidogenic human calcitonin FEBS Lett. 587 2013 569 574
36. A.J. Geddes, K.D. Parker, E.D. Atkins, and E. Beighton "Cross-beta" conformation in proteins J. Mol. Biol. 32 1968 343 358
37. M. Sunde, L.C. Serpell, M. Bartlam, P.E. Fraser, M.B. Pepys, and C.C. Blake Common core structure of amyloid fibrils by synchrotron X-ray diffraction J. Mol. Biol. 273 1997 729 739
38. S. Krimm, and J. Bandekar Vibrational spectroscopy and conformation of peptides, polypeptides, and proteins Adv. Protein Chem. 38 1986 181 364
39. P.I. Haris, and D. Chapman The conformational analysis of peptides using Fourier transform IR spectroscopy Biopolymers 37 1995 251 263
40. M. Jackson, and H.H. Mantsch The use and misuse of FTIR spectroscopy in the determination of protein structure Crit. Rev. Biochem. Mol. Biol. 30 1995 95 120
41. M. Sunde, and C. Blake The structure of amyloid fibrils by electron microscopy and X-ray diffraction Adv. Protein Chem. 50 1997 123 159
42. W.T. Astbury, S. Dickinson, and K. Bailey The X-ray interpretation of denaturation and the structure of the seed globulins Biochem. J. 29 1935 2351 2360
43. L. Goldschmidt, P.K. Teng, R. Riek, and D. Eisenberg Identifying the amylome, proteins capable of forming amyloid-like fibrils Proc. Natl. Acad. Sci. USA 107 2010 3487 3492
44. P. Westermark, C. Wernstedt, E. Wilander, D.W. Hayden, T.D. O'Brien, and K.H. Johnson Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells Proc. Natl. Acad. Sci. USA 84 1987 3881 3885
45. E. Maioli, C. Torricelli, A. Santucci, and A. Pacini Molecular assembly of endogenous and synthetic big atrial natriuretic peptide (ANP) and its amyloidogenic implications Biochim. Biophys. Acta 1500 2000 31 40
46. C. Torricelli, E. Capurro, A. Santucci, A. Paffetti, C. D'Ambrosio, A. Scaloni, E. Maioli, and A. Pacini Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation J. Mol. Endocrinol. 33 2004 335 341
47. T. Seidler, C. Pemberton, T. Yandle, E. Espiner, G. Nicholls, and M. Richards The amino terminal regions of proBNP and proANP oligomerise through leucine zipper-like coiled-coil motifs Biochem. Biophys. Res. Commun. 255 1999 495 501
48. S. Choi, N. Reixach, S. Connelly, S.M. Johnson, I.A. Wilson, and J.W. Kelly A substructure combination strategy to create potent and selective transthyretin kinetic stabilizers that prevent amyloidogenesis and cytotoxicity J. Am. Chem. Soc. 132 2010 1359 1370
49. S. Connelly, S. Choi, S.M. Johnson, J.W. Kelly, and I.A. Wilson Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses Curr. Opin. Struct. Biol. 20 2010 54 62